Crystal Structure
Crystallisation Method: EM
Corresponding Chain: A
Sequence Length: 1-571
Detail: Struture Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0353 | ||||
| Gene Name | SLC40A1 | ||||
| Protein Name | Iron-regulated transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Crystal Structure Crystallisation Method: EM Corresponding Chain: A Sequence Length: 1-571 Detail: Struture Info |
||||
| Synonyms | FPN1; Ferroportin-1; HFE4; IREG1; MST079; MSTP079; MTP1; SLC11A3; SLC40A1; Solute carrier family 40 member 1 | ||||
| DT Family | Ferroportin (FPN) Family ; | ||||
| Tissue Specificity | Detected in erythrocytes (at protein level).Expressed in placenta, intestine, muscle and spleen. | ||||
| Function | This transporter may be involved in iron export from duodenal epithelial cell and also in transfer of iron between maternal and fetal circulation. Mediates iron efflux in the presence of a ferroxidase (hephaestin and/or ceruloplasmin). | ||||
| Endogenous Substrate(s) | Co2+; Cu2+; Mn2+ | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(α) Microbiota Influence of This DT |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Zinc salts
|
Preclinical | Drug Info | Arthritis | FA5Z | [1] |
| References | |||||
| 1 | Ferroportin-mediated iron transport: expression and regulation. Biochim Biophys Acta. 2012 Sep;1823(9):1426-33. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.